Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension.
JR Zabludowski, C Zoccali, CG Isles, GD Murray, JI Robertson, GC Inglis, R Fraser, SG BallVolume:
17
Year:
1984
Language:
english
DOI:
10.1111/j.1365-2125.1984.tb02346.x
File:
PDF, 830 KB
english, 1984